![[up]](/style/images/multi_up.png)
Up a levelGroup by: Item Type | Date
Jump to: Journal article
Number of items: 3.
Journal article
Binder, H.; Willscher, E.; Löffler-Wirth, H.; Hopp, L.; Jones, D. T. W.; Pfister, S. M.; Kreuz, M.; Gramatzki, D.; Fortenbacher, E.; Hentschel, B.; Tatagiba, M.; Herrlinger, U.; Vatter, H.; Matschke, J.; Westphal, M.; Krex, D.; Schackert, G.; Tonn, J. C.; Schlegel, U.; Steiger, H. -J.; Wick, W.; Weber, R. G.; Weller, M. and Löffler, M.
(2019):
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
In: Acta Neuropathologica Communications, Vol. 7, 59
Gramatzki, D.; Kickingereder, P.; Hentschel, B.; Schramm, J.; Tonn, J. C.; Schackert, G.; Reifenberger, G.; Löffler, M.; Bendszus, M. and Weller, M.
(2016):
Extended temozolomide for newly diagnosed glioblastoma: an analysis of the German Glioma Network.
In: Neuro-Oncology, Vol. 18: p. 47
Schaich, M.; Kestel, L.; Pfirrmann, Markus; Robel, K.; Illmer, T.; Kramer, M.; Dill, C.; Ehninger, G.; Schackert, G. and Krex, D.
(2009):
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients.
In: Annals of Oncology, Vol. 20, No. 1: pp. 175-181